IMPACT OF VAMANA KARMA(THERAPEUTICALLY INDUCED EMESIS) AND TRIPHALA AND GUDUCHI CHURNA WITH MADHU ON THE MODULATION OF GUT MICROBIOTA.
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complicationsHealth Condition 2: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2020/12/030107
- Lead Sponsor
- All India Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
For Prameha(Type 2 Diabetes Mellitus) Individuals-
1. BMI� 20
2. Kaphaj/Kapha-pittaj Vikriti predominant individuals
3. Diagnosed cases of Prameha/Madhumeha/T2DM with either of the following-
a) Fasting plasma glucose values of � 7.0 mmol/L (126 mg/dl)
b) 2-h post-load plasma glucose � 11.1 mmol/L (200 mg/dl)
c) HbA1c � 6.5% (48 mmol/mol)
d) Random blood glucose � 11.1 mmol/L (200 mg/dl)
4. Chronicity: Up to 10 years
For Healthy Individuals
1. BMI� 20
2. Kaphaj/Kapha-pittaj Prakriti predominant Individuals as per Proforma for Prakriti Assessment by CSIR Ayurgenomics Unit- TRISUTRA CSIR-IGIB, NEW DELHI
3. Healthy individuals as per Proforma for Health Assessment by self-reporting of CSIR Ayurgenomics Unit- TRISUTRA CSIR-IGIB, NEW DELHI
Patients unfit for Snehana(Internal Oleation), Svedana(Sudation), Vamana(therapeutically induced emesis for internal bio-cleansing).
For Prameha(Type 2 Diabetes Mellitus)-
1. Patients with T2 DM exceeding the following plasma glucose limits-
a) Fasting plasma glucose values of � 300mg/dL
b) 2-h post-load plasma glucose�400mg/dL
c) Random blood glucose� 400mg/dL
2. Chronicity: More than 10 years.
3. Known cases of Severe systemic diseases like- Cardiac disease, pulmonary tuberculosis, severe lung disease, uncontrolled diabetes and pregnant women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method